Oxidative stress, hypoxia, and ischemia-like conditions increase the release of endogenous amino acids by distinct mechanisms in cultured retinal cells.
The aim of this study was to elucidate the mechanisms by which retinal cells release endogenous amino acids in response to ascorbate/Fe(2+)-induced oxidative stress, as compared with chemical hypoxia or ischemia. In the absence of stimulation, oxidative stress increased the release of aspartate, glutamate, taurine, and GABA only when Ca2+ was present. Under hypoxia or ischemia, the release of aspartate, glutamate, glycine, alanine, taurine, and GABA increased mainly by a Ca(2+)-independent mechanism. The increased release observed in N-methyl-D-glucamine+ medium suggested the reversal of the Na+-dependent amino acid transporters. Upon oxidative stress, the release of aspartate, glutamate, and GABA, occurring through the reversal of the Na(+)-dependent transporters, was reduced by about 30%, although the release of taurine was enhanced. An increased release of [3H]arachidonic acid and free radicals seems to affect the Na+-dependent transporters for glutamate and GABA in oxidized cells. All cell treatments increased [Ca2+]i (1.5 to twofold), although no differences were observed in membrane depolarization. The energy charge of cells submitted to hypoxia or oxidative stress was not changed. However, ischemia highly potentiated the reduction of the energy charge, as compared with hypoglycemia or hypoxia alone. The present work is important for understanding the mechanisms of amino acid release that occur in vivo upon oxidative stress, hypoxia, or ischemia, frequently associated with the impairment of energy metabolism.
Rego
A C
AC
Center for Neurosciences of Coimbra, University of Coimbra, Portugal.
Santos
M S
MS
Oliveira
C R
CR
D000249:Adenosine Monophosphate / Q000378:metabolism; D000409:Alanine / Q000378:metabolism; D000596:Amino Acids / Q000378:metabolism*; D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism; D001205:Ascorbic Acid / Q000494:pharmacology; D001224:Aspartic Acid / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D016923:Cell Death / Q000502:physiology; D015687:Cell Hypoxia / Q000502:physiology; D002478:Cells, Cultured / Q000187:drug effects / Q000378:metabolism; D002642:Chick Embryo; D018698:Glutamic Acid / Q000378:metabolism; D005998:Glycine / Q000378:metabolism; D007501:Iron / Q000494:pharmacology; D008564:Membrane Potentials / Q000502:physiology; D009498:Neurotoxins / Q000378:metabolism; D018384:Oxidative Stress / Q000502:physiology*; D012160:Retina / Q000166:cytology* / Q000378:metabolism; D013654:Taurine / Q000378:metabolism; D014316:Tritium / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D000596:Amino Acids; D009498:Neurotoxins; D014316:Tritium; D013654:Taurine; D016718:Arachidonic Acid; D001224:Aspartic Acid; D018698:Glutamic Acid; D000249:Adenosine Monophosphate; D005680:gamma-Aminobutyric Acid; D007501:Iron; D000409:Alanine; D001205:Ascorbic Acid; D002118:Calcium; D005998:Glycine